Review tracks shift toward bioactive compounds in pet food

Version 1

A new review in Veterinary Research Communications argues that companion animal nutrition is moving beyond broad “functional ingredient” claims toward a more precise focus on bioactive compounds, with the goal of linking specific ingredients to measurable physiologic effects in dogs and cats. The paper by Xinzi Guo, Nisha Farooq, and Hehe Liu proposes clearer definitions for functional ingredients, bioactive compounds, and dietary supplements in pet nutrition, and summarizes evidence across categories including probiotics, prebiotics, polyphenols, omega-3s, peptides, and other compounds used in commercial pet food. A second review in Animals adds detail on plant-derived ingredients, finding that polyphenols, plant extracts, microalgae, and some cannabinoid-related compounds are being studied for antioxidant, anti-inflammatory, immunomodulatory, and microbiome effects in dogs and cats, though the evidence base varies widely by ingredient and indication. Industry and regulatory context matters here, too: WSAVA continues to emphasize individualized nutrition and evidence-based diet selection, while FDA has also reiterated that CBD is not an approved ingredient in animal food, underscoring the gap between market interest and regulatory acceptance. (wsava.org)

Why it matters: For veterinary professionals, the reviews reflect a familiar tension in pet nutrition: pet parents increasingly want foods that promise gut, skin, immune, cognitive, or healthy aging benefits, but the science and regulatory footing behind those claims are uneven. The practical takeaway is that “functional” doesn’t automatically mean clinically meaningful. Reviews of the broader literature suggest some ingredient classes, especially microbiome-targeted ingredients and certain fatty acids or plant compounds, show promise, but outcomes often rely on formulation, dose, processing stability, and the population studied. That makes veterinary guidance, nutritional assessment, and careful interpretation of label claims especially important when discussing commercial diets or adjunctive supplements with pet parents. (petfoodindustry.com)

What to watch: Expect more pressure for ingredient-specific evidence, clearer claim substantiation, and closer scrutiny of how emerging functional compounds fit within evolving pet food ingredient review pathways and FDA oversight. (petfoodindustry.com)